CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)

Clinical trial NCT07443137 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07443137
Sponsor: Stanford University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Large-cell Lymphoma

Start date: 2026-07-01
Primary completion: 2028-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.